| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/27/1995 | CN1109051A 3-(phenylalkyl aminoalkyloxy)-5-phenlpyrazol, production, medium and pharmaceutical of same |
| 09/26/1995 | US5453488 Amino-substituted heterocycles as renin inhibitors |
| 09/26/1995 | US5453471 Gas phase polymerization process |
| 09/26/1995 | US5453442 Chromene derivative |
| 09/26/1995 | US5453441 Enzyme inhibitors and hypertensive agents |
| 09/26/1995 | US5453439 Hydroxylamine derivatives |
| 09/26/1995 | US5453424 Antiarrhythmia |
| 09/26/1995 | US5453421 Antiarrythmia/antiischemic agents; treatment of cardiovascular disorders |
| 09/26/1995 | US5453283 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
| 09/26/1995 | US5453272 Serine-proline-tyrosine-glycine-arginine-cysteine hexapeptide; immunosuppressant |
| 09/26/1995 | CA2145476A1 Sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation, and their use as pharmaceuticals |
| 09/26/1995 | CA1337124C Flavolignan derivatives, processes for the preparation thereof and pharmaceutical compositions containing these compounds |
| 09/26/1995 | CA1337122C Pharmacologically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same |
| 09/21/1995 | WO1995025110A1 Heterocyclic compounds, their preparation and use |
| 09/21/1995 | WO1995025104A1 Novel heterocyclic ethanolamine derivatives with beta-adrenoreceptor agonistic activity |
| 09/21/1995 | WO1995025091A2 Nipecotic acid derivatives as antithrombic compounds |
| 09/21/1995 | WO1995025087A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs |
| 09/21/1995 | WO1995024908A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 09/21/1995 | WO1995024905A1 Use of triterpenesaponins, such as notoginsenoside r1 (r1) and/or astragaloside (iv) for preparing medicaments |
| 09/21/1995 | WO1995024903A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 09/21/1995 | WO1995024898A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
| 09/21/1995 | WO1995021612A3 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 09/21/1995 | WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
| 09/21/1995 | DE4408497A1 New bi:phenyl-methyl-benzimidazole derivs. |
| 09/21/1995 | CA2185670A1 Heterocyclic compounds, their preparation and use |
| 09/21/1995 | CA2184753A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
| 09/21/1995 | CA2163027A1 Nipecotic acid derivatives as antithrombic compounds |
| 09/21/1995 | CA2162916A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs |
| 09/20/1995 | EP0672418A2 Use of adenosine monophosphate deaminase inhibitor for increasing extracellular adenosine |
| 09/20/1995 | EP0672412A2 Use of 3,4-diphenyl chromans for the manufacture of a medicament for lowering cholesterol levels |
| 09/20/1995 | EP0672151A1 Inhibitors of ced-3 and related proteins |
| 09/20/1995 | EP0672058A1 Calcium channel blocking polypeptides from heteropoda venatoria |
| 09/20/1995 | EP0672055A1 Neuropeptide y antagonists |
| 09/20/1995 | EP0672054A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
| 09/20/1995 | EP0672053A1 Treatment of septic shock with conjugated biologically active peptides |
| 09/20/1995 | EP0672034A1 Benzimidazole compounds which inhibit platelet aggregation |
| 09/20/1995 | EP0671951A1 Humanized antibodies reactive with l-selectin |
| 09/20/1995 | EP0671924A1 Digitalis-like compounds |
| 09/20/1995 | EP0671911A1 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 09/20/1995 | EP0576475B1 Isoindoles having cardiovascular activity |
| 09/20/1995 | EP0563358B1 9-substituted bicyclo [3.3.0]octane derivatives, for use as txa2 antagonists |
| 09/20/1995 | EP0489877B1 Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones |
| 09/20/1995 | CN1029770C Controlled release bases for pharmaceuticals |
| 09/19/1995 | US5451608 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovasular system, processes for their preparation and pharmaceutical compositions containing them |
| 09/19/1995 | US5451596 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 09/19/1995 | US5451518 Purified human ceramide-activated protein kinase |
| 09/19/1995 | CA1337074C 1,4-dihydropyridine-threonine derivatives with cardiovascular activity |
| 09/19/1995 | CA1337073C 4 amino quinolines and naphthyridines, process for their preparation and their use as medicines |
| 09/19/1995 | CA1337072C 5-substituted [4,5-c] imidazopyridines |
| 09/15/1995 | CA2144374A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/14/1995 | WO1995024650A2 Methods of diagnosing and treating preeclampsia |
| 09/14/1995 | WO1995024501A1 Compositions for the inhibition of tnf formation and uses thereof |
| 09/14/1995 | WO1995024473A1 Vascular endothelial growth factor 2 |
| 09/14/1995 | WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 09/14/1995 | WO1995024414A1 Fibroblast growth factor-10 |
| 09/14/1995 | WO1995024393A1 Naphthalene derivatives as prostaglandin i2 agonists |
| 09/14/1995 | WO1995024208A1 Glioblastoma-derived angiogenesis inhibiting factor |
| 09/14/1995 | WO1995024207A1 Composition for the treatment of lung disease |
| 09/14/1995 | WO1995024202A1 Ribozyme therapy for restenosis |
| 09/14/1995 | WO1995024200A1 Method for treating 5ht2b receptor related conditions |
| 09/14/1995 | WO1995024192A1 Isoxazoline compounds as 5-lipoxygenase inhibitors |
| 09/14/1995 | CA2414016A1 Vascular endothelial growth factor 2 |
| 09/14/1995 | CA2185236A1 Method for treating 5ht2b receptor related conditions |
| 09/14/1995 | CA2185162A1 Compositions for the inhibition of tnf formation and uses thereof |
| 09/14/1995 | CA2185104A1 Naphthalene derivatives as prostaglandin 12 agonists |
| 09/14/1995 | CA2184989A1 Ribozyme therapy for restenosis |
| 09/14/1995 | CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 09/14/1995 | CA2184385A1 Composition for the treatment of lung disease |
| 09/14/1995 | CA2184358A1 Glioblastoma-derived angiogenesis inhibiting factor |
| 09/14/1995 | CA2183961A1 Fibroblast growth factor-10 |
| 09/13/1995 | EP0671414A1 Antithrombotic |
| 09/13/1995 | EP0671407A2 Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors |
| 09/13/1995 | EP0671171A1 Use of HMG COA reductase inhibitor for the manufacture of a medicament for proventing or reducing risks of onset of cardiovascular events |
| 09/13/1995 | EP0671170A1 Use of pravastatin for slowing progression coronary artery atherosclerosis |
| 09/13/1995 | EP0670838A1 SUBSTITUTED-PHENYL(N,N'-CYCLOALKYL/ALKYL CARBOXAMIDE)-1H/3H-IMIDAZO 4,5-b]PYRIDINE COMPOUNDS AS PAF ANTAGONISTS |
| 09/13/1995 | EP0670833A1 Nitroxy compounds with pharmaceutical properties |
| 09/13/1995 | EP0670724A1 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis |
| 09/13/1995 | EP0670720A1 Enzyme inhibitors |
| 09/13/1995 | EP0563094B1 Pharmaceutical compositions |
| 09/13/1995 | EP0541593B1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
| 09/13/1995 | CN1108257A Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives |
| 09/13/1995 | CN1108254A Process for the preparation of alpha-tocopherol derivatives |
| 09/13/1995 | CN1108248A Glycoprotein IIB/IIIA antagonists |
| 09/13/1995 | CN1108240A Excitatory amino acid receptor antagonists |
| 09/13/1995 | CN1108123A Traditional Chinese medicine pill "Guan-mai-dan" for curing coronary heart disease and the like |
| 09/13/1995 | CN1108093A Methods for inhibiting vasomotor symptons and attending psychological disturbances surrounding post-menopausal syndrome |
| 09/13/1995 | CN1108090A Methods for inhibiting LDL oxidation and atherosclerosis |
| 09/13/1995 | CN1029737C Process for preparing aminoalkylketones derivatives and use in therapy |
| 09/12/1995 | US5449814 Dehydration; Michael condensation |
| 09/12/1995 | US5449674 Prostaglandin E2 inhibitors |
| 09/12/1995 | US5449662 Atrial natriuretic peptide clearance inhibitors which resist degradation |
| 09/12/1995 | US5449661 Angiotensin converting enzyme inhibitor and method for preparing same |
| 09/12/1995 | CA2143462A1 Method for slowing progression of coronary artery atherosclerosis employing pravastatin |
| 09/12/1995 | CA1336975C Benzazepine and benzothiazepine derivatives |
| 09/12/1995 | CA1336963C Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion |
| 09/12/1995 | CA1336961C Long lasting composition of propafenone and quinidine for treatment of cardiac conditions |
| 09/12/1995 | CA1336953C Method of preventing or reducing adverse reactions to protamine using a thromboxane a _receptor antagonist |
| 09/08/1995 | WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
| 09/08/1995 | WO1995023857A1 Yeast strains and modified albumins |
| 09/08/1995 | WO1995023806A2 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |